Business
Is the CSL (ASX:CSL) share price too cheap to ignore?
It has been an unusually disappointing year for the CSL Limited (ASX: CSL) share price.
The biotechnology giant’s shares have thoroughly underperformed the market during this time and are trading significantly lower than their 52-week high.
In fact, with the CSL share price currently fetching $263.40, it is down 21% from its high of $332.68.
Why is the CSL share price under pressure?
The weakness in the CSL share price has been driven largely by concerns over plasma collection headwinds.
As well as being impacted by social distancing initiatives, COVID stimulus payments have prevented some traditional donors from donating. This has led to a reduction in supply and an increase in costs.
Given how plasma is a vital component in…
-
Noosa News13 hours agoMitch Power Quick Shear event gets men talking about mental health
-
General15 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why
-
Noosa News7 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs
-
General6 hours agoAlgal bloom fears grow as video shows dead fish in ‘neon green’ waters near Ardrossan